Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 20, 2020 06:00 ET | Source: Immuron Limited

US DoD Naval Medical Research Center Receives FDA Guidance on the clinical development plans for new oral therapeutic

Key Points NMRC received guidance from the FDA on the development of a new oral therapeutic targeting Campylobacter and ETEC Two human phase II clinical trials to be conducted in 2021One trial will...
June 19, 2020 06:00 ET | Source: Immuron Limited

Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense

Key Points Immuron executes a Research Agreement with The Henry M. Jackson Foundation for Advancement of Military Medicine Inc.Immuron executes a Research Agreement with CSIRO to develop a new oral...
June 09, 2020 06:00 ET | Source: Immuron Limited

US DoD Naval Medical Research Center Requests Meeting with FDA for Guidance on two Phase 2 trials to Prevent Acute Infectious Diarrhea

Key Points NMRC requests Pre-IND meeting with FDA on the development of a new oral therapeutic targeting Campylobacter and ETEC Two human phase II clinical trials to be conducted in 2021One trial...